• Contact Us

Common Painkillers Could Increase Cancer Survival Rates by a Third

on Tuesday, 12 March 2019.

Researchers at the University of California, San Francisco have found that the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and aspirin, boosted survival rates in head and neck cancer sufferers from 25% to 78%.

The increase in survival rate was linked to the cancer containing a specific mutated gene known as PIK3CA, which is found in approximately one third of head and neck cancers.

It is hoped that despite the study focusing on head and neck cancer patients, that any cancer sufferer whose cancer contains the PIK3CA mutation gene could gain a more favourable outcome through the use of NSAIDs.


For more information, please contact a member of our Pharmaceuticals & Life Sciences team on, or complete the form below. 

 

Get in Touch

First name(*)
Please enter your first name.

Last name(*)
Invalid Input

Email address(*)
Please enter a valid email address

Telephone
Please insert your telephone number.

How would you like us to contact you?

Invalid Input

How can we help you?(*)
Please limit text to alphanumeric and the following special characters: £.%,'"?!£$%^&*()_-=+:;@#`

See our privacy page to find out how we use and protect your data.

Invalid Input